LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
1
65.61 770.25 1571 9736 0.1614 0.2150
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
67.83 770.25 1168 10078 0.1159 0.1188
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
67.83 770.25 1662 10078 0.1649 0.2304
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
70.05 770.25 1193 10413 0.1146 0.1235
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
70.05 770.25 1660 10413 0.1594 0.2268
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
72.27 770.25 1158 10730 0.1079 0.1133
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
72.27 770.25 1666 10730 0.1553 0.2251
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
74.50 770.25 1197 10991 0.1089 0.1218
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
74.50 770.25 1785 10991 0.1624 0.2450
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
76.75 770.25 1177 11262 0.1045 0.1158
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
76.75 770.25 1595 11262 0.1416 0.2069
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
78.98 770.25 1244 11518 0.1080 0.1307
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
78.98 770.25 1910 11518 0.1658 0.2620
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
81.20 770.25 1335 11766 0.1135 0.1501
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
81.20 770.25 1961 11766 0.1667 0.2682
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
83.42 770.25 1431 12031 0.1189 0.1691
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
83.42 770.25 1839 12031 0.1528 0.2454
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
85.64 770.25 1392 12287 0.1133 0.1596
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
85.64 770.25 2026 12287 0.1649 0.2738
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
87.86 770.25 1472 12543 0.1174 0.1746
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
87.86 770.25 1988 12543 0.1585 0.2656
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
3.1623
3.21 770.25 977 904 1.0800 1.7868
MN20160304_L02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
3.21 770.25 1010 904 1.1165 2.2159
MN20160304_L02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
5.44 770.25 1042 1012 1.0289 1.1495
MN20160304_L02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
5.44 770.25 1068 1012 1.0546 1.2880
MN20160304_L02
K04